Friday, January 9, 2026

The Cancer News

AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER

Health Equity

Health inequities persist in the U.S. and globally, especially in low- and middle-income countries, where limited access to care leads to poorer outcomes. This section explores cancer through the lens of equity, highlighting emerging research, tools, and technologies working to close the gap and advance more just, inclusive cancer care.

March is Colorectal Cancer Awareness Month with a blue ribbon symbolizing support for awareness and prevention.
Health Equity

National Colorectal Cancer Awareness Month

By Binaytara Team

Colorectal cancer is preventable with early screening. Learn about risk factors, symptoms, and prevention strategies this National Colorectal Cancer Awareness Month

ASCO24 LAURA Trial Summary
Health Equity

ASCO24 LAURA Trial Summary

By Editorial Team

By: Zhiting Tang1, Lei Deng2 1\. [Unity Hospital](https://www.rochesterregional.org/locations/unity-hospital), Rochester Regional Health, Rochester, NY 2\. [University of Washington](https://www.uw...

ADRIATIC: durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC)
Health Equity

ADRIATIC: durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC)

By Editorial Team

By: Tiantian Zhang1, Yiqun Han2, Lei Deng3 1. [Department of Internal Medicine, University of Central Florida](https://med.ucf.edu/), Pensacola, FL 2. [Mayo Clinic](https://www.mayoclinic.org/patien...

A Digital Solution: Clinical Trials Without Adverse Events
Health Equity

A Digital Solution: Clinical Trials Without Adverse Events

By The Cancer News Team

Clinical trials are the process by which progress is made in clinical care. It is accepted and understood that participants in clinical trials must be assessed for both toxicity and efficacy, but what...

A Latino Lens
Health Equity

A Latino Lens

By Editorial Team

### **Listening to the Community to Fuel Outreach and Engagement** **By Dr. Kelly Meza**   Dr. Ramirez and her team at Mays Cancer Center are dedicated to tackling the unequal impact of cancer an...

A 12 Year Journey to Enhance Minority Enrollment in Clinical Trials
Health Equity

A 12 Year Journey to Enhance Minority Enrollment in Clinical Trials

By Binaytara Team

Dr. Sharad Ghamande, MD, FACOG delivered an insightful presentation titled "Can We Increase Accrual of Minorities in Rural Areas of the Country? A 12-Year Journey," shedding light on the imperative ne...

Access to Medications: Cases Studies in Solutions
Health Equity

Access to Medications: Cases Studies in Solutions

By Editorial Team

**By Dr. Richa Parikh** In this talk, Dr. Dan Milner discusses various strategies to improve access to oncology drugs to patients both in the US and globally, in an equitable manner to mitigate disp...

Best Practices in Supporting LGBTQ+ Communities
Health Equity

Best Practices in Supporting LGBTQ+ Communities

By Editorial Team

At The Summit on Cancer Health Disparities 2024, in the session titled “Best Practices in Serving LGBTQ+ Communities,” Nakita Venus (they/them) and Elle Brooks (she/they) from Seattle’s LGBTQ Center, ...

Dr. Finkelstein
Health Equity

Artificial Intelligence to Facilitate Cancer Care

By Dr. Brenda Santellano

**By Dr. Brenda Santellano -** **Research Associate at Georgia Cancer Center** [Dr. Jospeph Finkelstein, MD, PhD, FAMIA, FACMI](https://medicine.utah.edu/faculty/joseph-finkelstein) explored the tra...

Antibody Drug Conjugates
Health Equity

Antibody Drug Conjugates

By Editorial Team

_**Author**: **Dr. Arya Mariam** **Roy** from Roswell Park Comprehensive Cancer Center_   **What are antibody drug conjugates (ADCs)?** Antibody drug conjugates (ADCs) are newer targeted medicines...

Page 3 of 5
(43 articles)